Merck Frosst
MerckFrosst Home Contact Us Français
MerckFrosst HomeContact UsFrançais
Patients and Caregivers

Osteoporosis

What is your SCORE®?

SCORE® Questionnaire

Osteoporosis Evaluation SCORE® Questionnaire

If you are a postmenopausal woman between 50 and 70 years of age, answer the questions below to the best of your ability. These answers may help your doctor determine if there is a need for further testing for osteoporosis.

 

1. What is your current age?

  (years)  

2. What is your race or ethnic group?
    (Check one)
African-American
Caucasian
Asian
Native Canadian/
First Nation
Other

3. Have you ever been treated for or told you have
    rheumatoid arthritis?
Yes No

4. Since the age of 45, have you experienced a fracture
    (broken bone) at any of the following sites?
    (Please provide an answer for each of the three sites noted to the right.)
  Yes No
Hip
Rib
Wrist

5. Do you currently take or have you ever taken estrogen?
    (Examples include Premarin®, Estraderm®, Estring®, Estrace®, Ogen® †)
Yes No

6. What is your current weight?

     (Enter your current weight in lbs. If you wish to convert your weight to lbs from kg, enter your weight in the box to the left, and click the "kg to lbs" button to obtain result.)


         		 


 lbs  
     final  SCORE®   

What does your SCORE® mean?

If you are between the age of 50 and 59 and your final SCORE® is 6 or greater, you should be evaluated further for osteoporosis.

If you are between the age of 60 and 70 and your final SCORE® is 8 or greater, you should be evaluated further for osteoporosis.

Note:
While this questionnaire is not 100% predictive of osteoporosis, it may strongly indicate the need for appropriate evaluation.

None of the information that you provide can be received or collected by Merck Frosst Canada Ltd. or any other organization.

This product information is intended only for residents of Canada.


®Registered Trademark of Merck & Co., Inc. Used under license.

† PrPremarin® (conjugated estrogens) is a registered trademark of Wyeth Canada Inc.

PrEstraderm® (estradiol-17ß) is a registered trademark of Novartis Pharmaceuticals Canada Inc.

PrEstring® (estradiol) and Ogen® (estropipate) are registered trademarks of Pharmacia Canada Inc.

PrEstrace® (estradiol-17ß [micronized]) is a registered trademark of Shire Biochem Inc.

Merck Frosst

Printer friendly
Email a friend

This site is for residents of Canada. / This site was updated on October 26, 2011.